Economic Survey Projects 6.8-7.2% GDP Growth for FY26

India's Economic Survey 2025-26 projects GDP growth between 6.8-7.2% for next fiscal year, citing cumulative reform impact. It addresses rupee undervaluation, fiscal discipline, and global opportunities amid uncertainty.

Rupee Hits Lifetime Low: Economic Survey Reveals Causes

Indian rupee becomes worst-performing Asian currency in 2025, starts 2026 at record low of 92 against US dollar. Economic Survey cites geopolitics, trade deficit, and strategic power gap as key factors behind depreciation.

Budget 2026: Track but Keep Long-Term Investment Focus

The Union Budget 2026 influences sectors and taxation, but investors should avoid knee-jerk portfolio changes. Long-term strategies and index funds offer stability amid budget-induced market volatility.

Pharma Stock Q3 Revenue Up 45% YoY, Share Price Rises

A leading pharmaceutical company reports a 45% year-on-year increase in revenue for Q3, driving significant investor interest and a rise in share price. The results highlight strong performance in key markets.

InvAscent Writes Bigger Pharma Cheques Amid Rising Costs

Hyderabad-based PE firm InvAscent increases investment ticket sizes in pharmaceuticals to $80-100 million deals, driven by higher regulatory and manufacturing costs. The firm allocates 50% to pharma, 30% to healthcare, and 20% to allied segments.

Metal Stocks Soar: Nifty Metal Index Hits Record High

Hindustan Copper, National Aluminium, and Jindal Steel lead Nifty Metal to a record high, fueled by a weak US dollar and surging base metal prices. The index gains 2.42%, extending its rally for the fourth straight session.

UAE's Rail Revolution: Etihad Rail 2026 Launch

The United Arab Emirates prepares for a transportation transformation as Etihad Rail announces passenger services launching in 2026, connecting all seven emirates with modern trains and reducing travel times significantly.

Mala Gaonkar's $6B Hedge Fund Success Story

Mala Gaonkar built SurgoCap Partners into a $6 billion hedge fund in three years, becoming the largest female-led debut in the industry. Her journey from Bengaluru to New York showcases women's growing influence in finance.

Japan Bond Turmoil Warning for India's Budget Makers

Japan's bond market volatility highlights investor sensitivity to fiscal slippage. As India prepares to shift to debt-level fiscal targets, maintaining credibility while managing spending pressures becomes crucial.

Volkswagen Tayron R-Line SUV Launched in India

Volkswagen India unveils the new Tayron R-Line SUV, positioned above Tiguan. Priced Rs 45-50 lakh, it features 7 seats, 204hp engine, and rivals Fortuner, Gloster. Launch expected February 2026.

Pavna Industries Rises on Subsidiary Investment Approval

Pavna Industries shares rose 2.11% to ₹17.92 despite weak market sentiment after the board approved a ₹4 lakh investment in subsidiary Pavna SMC, acquiring an 80% stake. The company reported a 49% YoY decline in Q2 net profit.

Sensex, Nifty Drop Ahead of Crucial Federal Budget

Indian stock markets declined on Thursday, with Nifty 50 down 0.23% and Sensex falling 0.21%, as investor attention shifted from EU trade agreement to upcoming federal budget. Markets will hold special Sunday session for budget announcement.

Sebi's Bond Liquidity Window Fails to Catch On

India's corporate bond liquidity window, introduced in November 2024, sees minimal adoption due to low issuer incentives, excessive regulations, and balance sheet uncertainties.

Piramal Pharma Q3 Net Loss at ₹136 Crore

Piramal Pharma reported a consolidated net loss of ₹136 crore for Q3 FY26, compared to a profit of ₹4 crore last year. Revenue declined to ₹2,140 crore due to inventory destocking and slower order inflows.

Page 145 of 828